COVID-19 POC Testing Kits Market
COVID-19 POC Testing Kits Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
COVID-19 POC Testing Kits Market
Size and Growth
The COVID-19 point-of-care (POC) testing kits market is experiencing significant growth driven by ongoing pandemic demands and technological advancements. Valued at approximately $5 billion in 2023, the market is projected to expand due to increased accessibility, rapid testing needs, and shifts towards decentralized healthcare solutions, enhancing patient outcomes globally. Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ "Abbott Laboratories"
◍ "Mylab Discovery Solutions Pvt. Ltd"
◍ "Convergent Technologies"
◍ "Thermo Fisher Scientific
◍ Inc."
◍ "F. Hoffmann-la Roche Ltd"
◍ "Danaher"
◍ "BGI"
◍ "Cue Health Inc."
◍ "Sd Biosensor
◍ Inc"
◍ "Quest Diagnostics"
The COVID-19 POC Testing Kits Market features key players like Abbott Laboratories, Mylab, Thermo Fisher, and Roche. These companies contribute by innovating testing technologies, expanding distribution, and enhancing accessibility. Their efforts drive market growth through increased testing adoption and improved healthcare responses. Sales figures include:
- Abbott: $43.1 billion (2022)
- Roche: $63 billion (2022)
- Thermo Fisher: $40.4 billion (2022)
Request Sample Report
Market Segmentation
By Application
◍ "Hospitals"
◍ "Diagnostic Centers and Clinics"
◍ "Home Care"
◍ "Others"
By Product
◍ "Nasopharyngeal Swabs"
◍ "Nasal Swabs"
◍ "Saliva"
◍ "Oropharyngeal Swabs"
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
